These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35523485)

  • 1. Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial.
    Zhang H; Xue Y; Pan T; Zhu X; Chong H; Xu C; Fan F; Cao H; Zhang B; Pan J; Zhou Q; Yang G; Wang J; Wang DJ
    BMJ Open; 2022 May; 12(5):e056264. PubMed ID: 35523485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
    Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
    J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
    Kobayashi H; Tohyama S; Ichimura H; Ohashi N; Chino S; Soma Y; Tani H; Tanaka Y; Yang X; Shiba N; Kadota S; Haga K; Moriwaki T; Morita-Umei Y; Umei TC; Sekine O; Kishino Y; Kanazawa H; Kawagishi H; Yamada M; Narita K; Naito T; Seto T; Kuwahara K; Shiba Y; Fukuda K
    Circulation; 2024 Apr; ():. PubMed ID: 38666382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocytes from CCND2-overexpressing human induced-pluripotent stem cells repopulate the myocardial scar in mice: A 6-month study.
    Fan C; Fast VG; Tang Y; Zhao M; Turner JF; Krishnamurthy P; Rogers JM; Valarmathi MT; Yang J; Zhu W; Zhang J
    J Mol Cell Cardiol; 2019 Dec; 137():25-33. PubMed ID: 31629738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments.
    Kishino Y; Fukuda K
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch in Rats With Heart Failure.
    Lancaster JJ; Sanchez P; Repetti GG; Juneman E; Pandey AC; Chinyere IR; Moukabary T; LaHood N; Daugherty SL; Goldman S
    Ann Thorac Surg; 2019 Oct; 108(4):1169-1177. PubMed ID: 31075250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
    Prajapati C; Ojala M; Aalto-Setälä K
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Rampoldi A; Singh M; Wu Q; Duan M; Jha R; Maxwell JT; Bradner JM; Zhang X; Saraf A; Miller GW; Gibson G; Brown LA; Xu C
    Toxicol Sci; 2019 May; 169(1):280-292. PubMed ID: 31059573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cell-derived three-dimensional cardiomyocyte tissues ameliorate the rat ischemic myocardium by remodeling the extracellular matrix and cardiac protein phenotype.
    Yokoyama J; Miyagawa S; Akagi T; Akashi M; Sawa Y
    PLoS One; 2021; 16(3):e0245571. PubMed ID: 33720933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy combined with coronary artery bypass grafting in ischaemic heart failure patients: long-term results of the RESCUE study.
    Romanov A; Goscinska-Bis K; Bis J; Chernyavskiy A; Prokhorova D; Syrtseva Y; Shabanov V; Alsov S; Karaskov A; Deja M; Krejca M; Pokushalov E
    Eur J Cardiothorac Surg; 2016 Jul; 50(1):36-41. PubMed ID: 26719401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.